foli-doce 400/2 microgramos comprimidos
itf abacus farma s.a. - cianocobalamina; folico acido - comprimido - 2 microgramos/400 microgramos - cianocobalamina 2 microgramos; folico acido 400 microgramos - cianocobalamina, combinaciones con
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - agentes antineoplásicos - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
siklos
theravia - hidroxicarbamida - anemia, falciforme - agentes antineoplásicos - siklos está indicado para la prevención de la repetición de dolorosa crisis vaso-oclusivas, incluyendo el síndrome torácico agudo en la edad pediátrica y adulta de los pacientes que sufren de los síntomas de células falciformes, síndrome de.
linezolid
abaris healthcare pvt. ltd. - linezolid - solución para infusión iv - 200 mg/100 ml
fluconazol
abaris healthcare pvt. ltd. - fluconazol - solución para infusión iv - 200 mg/100 ml
levofloxacino
abaris healthcare pvt. ltd. - levofloxacino (eq. a 512 mg de levofloxacino hemihidrato) - solución para infusión iv - 500 mg/100 ml
glucosa 10 %
abaris healthcare pvt. ltd. - glucosa anhidra - solución para infusión iv - 10 g/100 ml
opfolda
amicus therapeutics europe limited - miglustat - enfermedad de almacenamiento de glucógeno tipo ii - otros productos del metabolismo y del tracto alimentario - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).
paracetamol 1 g
abaris healthcare pvt. ltd. india - paracetamol 1 g - solucion inyectable - cada ml contiene: paracetamol 10 mg
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - enfermedad de almacenamiento de glucógeno tipo ii - otros tracto alimentario y metabolismo de los productos, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).